Last updated: 2026-09-06 22:45:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
InMode Ltd. (INMD) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $14,91, with a market capitalization of $860,29M and a P/E ratio of 14,44. Over the past 52 weeks, its price has ranged from $12,72 to $16,74. This page covers its latest market performance, valuation, price trends and company information.
$860,29M | |
$14,79 | |
$99,27 | |
$2,15 | |
$14,84 | |
165,02K | |
-- | |
14,44 | |
$16,74 | |
$12,72 | |
-- | |
-- |
InMode Ltd. (INMD) last closed at $14,84 as of 2026-09-04 23:31:00, unchanged from the previous close of $14,84.
During the latest regular trading session, INMD traded between $2,15 and $99,27, with a volume of 165,02K shares. The closing price was near the lower end and near the middle of its 52-week range.
Over the past seven days, InMode Ltd. (INMD) moved from $14,85 to $14,91, representing a gain of 0,37% ($0,05).
The stock traded between $14,77 and $14,93 during the period. The latest price is near the upper end of the 7-day range, indicating range-bound.
The average daily volume was 523,30 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 54,4%
INMD is currently trading at $14,91, placing it 54,4% of the way from its 52-week low of $12,72 to its 52-week high of $16,74. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.
| Employees | 660 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of InMode Ltd. (INMD) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.